BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9754242)

  • 1. [In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS].
    Leissner P; Calenda V; Marigliano M; Sanhadji K; Touraine JL; Pavirani A; Mehtali M
    Ann Biol Clin (Paris); 1998; 56(2):167-73. PubMed ID: 9754242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice.
    Sanhadji K; Leissner P; Firouzi R; Pelloquin F; Kehrli L; Marigliano M; Calenda V; Ottmann M; Tardy JC; Mehtali M; Touraine JL
    AIDS; 1997 Jul; 11(8):977-86. PubMed ID: 9223731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL; Sanhadji K; Sembeil R
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals.
    Vieillard V; Lauret E; Maguer V; Jacomet C; Rozenbaum W; Gazzolo L; De Maeyer E
    AIDS; 1995 Nov; 9(11):1221-8. PubMed ID: 8561974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251.
    Gay W; Lauret E; Boson B; Larghero J; Matheux F; Peyramaure S; Rousseau V; Dormont D; De Maeyer E; Le Grand R
    Retrovirology; 2004 Sep; 1():29. PubMed ID: 15447786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
    Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
    Shiau AL; Lin CY; Tzai TS; Wu CL
    Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV replication: a powerful antiviral strategy by IFN-beta gene delivery in CD4+ cells.
    Brule F; Khatissian E; Benani A; Bodeux A; Montagnier L; Piette J; Lauret E; Ravet E
    Biochem Pharmacol; 2007 Sep; 74(6):898-910. PubMed ID: 17662695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
    Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
    Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K; Tüting T; Tahara H; Lotze MT
    Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
    Shirazi Y; Pitha PM
    J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable antiviral expression (SAVE) as an approach to somatic cell gene therapy directed against HIV infection.
    De Maeyer E; Seif I; Vieillard V; Cases O; Rousseau V; De Maeyer-Guignard J; Lauret E
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1288-93. PubMed ID: 7705744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS.
    Manca F; Fenoglio D; Franchin E; Saverino D; Li Pira G; Buffa F; Bignardi D; Del Pup L; Palù G
    Gene Ther; 1997 Nov; 4(11):1216-24. PubMed ID: 9425445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.